AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $186,000 | +50.0% | 16,116 | +29.9% | 0.00% | +33.3% |
| Q2 2019 | $124,000 | +2.5% | 12,410 | +32.2% | 0.00% | 0.0% |
| Q1 2019 | $121,000 | -15.4% | 9,384 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $143,000 | -23.9% | 9,384 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $188,000 | +2.7% | 9,384 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $183,000 | -3.2% | 9,384 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $189,000 | +75.0% | 9,384 | +15.0% | 0.00% | +100.0% |
| Q4 2017 | $108,000 | -7.7% | 8,160 | +29.0% | 0.00% | -33.3% |
| Q3 2017 | $117,000 | +39.3% | 6,324 | +37.8% | 0.00% | +50.0% |
| Q2 2017 | $84,000 | +68.0% | 4,590 | +107.7% | 0.00% | +100.0% |
| Q1 2017 | $50,000 | -31.5% | 2,210 | +4.8% | 0.00% | -50.0% |
| Q4 2016 | $73,000 | – | 2,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,650,000 | $48,893,000 | 3.10% |
| Voce Capital Management LLC | 110,789 | $2,044,000 | 2.72% |
| Palo Alto Investors LP | 3,441,233 | $63,491,000 | 2.67% |
| FALCON POINT CAPITAL, LLC | 839,477 | $13,180,000 | 1.91% |
| EII CAPITAL MANAGEMENT, INC. | 119,690 | $2,208,000 | 0.83% |
| CLARK ESTATES INC/NY | 163,300 | $3,013,000 | 0.50% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 38,358 | $708,000 | 0.50% |
| Jabre Capital Partners S.A. | 120,000 | $2,214,000 | 0.43% |
| Credit Capital Investments LLC | 15,000 | $277,000 | 0.31% |
| Alambic Investment Management, L.P. | 151,442 | $2,794,000 | 0.30% |